HealthQuill Health
The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global health agency reported an 8.9% rise in global prevalence in cases arising in the UK, France and Sweden.
Drugs Health Pharma

Omicron mutant BA.2.86 reclassified as ‘variant of interest’ by WHO 

HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global.

Read More
The USFDA is probing cancer therapies of Gilead Sciences, Johnson & Johnson and Novartis following reports of malignancies in patients who received treatment.
Drugs Health Pharma

FDA probing T cell cancer therapies of Gilead Sciences, Novartis, J & J

HQ Team November 29, 2023: The USFDA is probing cancer therapies of Gilead Sciences, Johnson & Johnson and Novartis following reports of malignancies.

Read More
The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory at the Milner Therapeutics Institute
Drugs Health Pharma

Cambridge Univ, AstraZeneca, MRC to set up genomics laboratory

HQ Team November 29, 2023: The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory.

Read More
Alembic FDA nod
Climate Health Pharma

Environment, lifestyle behind epidemic of autoimmune diseases

HQ Team November 28, 2023: An escalating global crisis is unfolding as an increasing number of individuals grapple with autoimmune diseases, conditions wherein.

Read More
German biotechnology company, BioNTech SE announced a $ 90 million program in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a  vaccine for mpox.
Health Medical Pharma

WHO confirms 1st case of sexual spread of Mpox in Congo

HQ Team November 25, 2023: The first Mpox patient to contact the disease through sexual contact has been confirmed by the WHO in.

Read More
A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching, according to researchers at Harvard Medical School.
Drugs Health Pharma

Bacterium S. aureus behind happiness of having to scratch for every itch

HQ Team November 24, 2023: A bacterium, staphylococcus aureus, single-handedly imbalances the equilibrium of micro-organisms, that keep the skin healthy, and cause itching,.

Read More
One in five children and young people in England aged between eight and 25 had a probable mental disorder in 2023, a report by the National Health Service, a publicly-funded healthcare system, found.
Drugs Health Pharma

1 in 5 kids, young people in England probably had a mental disorder in 2023

HQ Team November 24, 2023: One in five children and young people in England aged between eight and 25 had a probable mental.

Read More
The World Health Organisation is monitoring an increase in children’s illness caused by pathogens, including acute respiratory syndrome coronavirus 2, in northern China.
Climate Health Pharma

WHO keeping an eye on a surge of respiratory illness in northern China

The World Health Organization is monitoring an increase in children’s illness caused by pathogens, including acute respiratory syndrome coronavirus 2, in northern China.

Read More
— at a time when President Emmanuel Macron is taking steps to stem the country’s industrial decline.
Drugs Health Pharma

Novo Nordisk invests $2.3b in France for diabetes, obesity drugs

HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..

Read More
hospital hygiene
Drugs Health Medical

Study reveals bleach ineffective against common superbug in hospitals

HQ Team November 23, 2023: The widely used disinfectant, bleach, commonly employed in hospitals for cleaning medical equipment and surfaces is ineffective against.

Read More